Introduction
Women undergoing treatment with IVF face an ∼ 20-fold increased risk of twins and a 400-fold increased risk of higher order pregnancies (triplets or more) (Martin and Welch, 1998) . In 2002, 36.2% out of 29 423 IVF pregnancies in the USA were multiple fetus pregnancies (SART, 2002) . In Europe, where two embryo transfers are the norm in many centres, 24% of all IVF infants born in 2001 were twins (Nyboe et al., 2005) .
Twins are associated with higher maternal and perinatal complications including miscarriage, pregnancy-induced hypertension, ante-partum haemorrhage, gestational diabetes, operative delivery, prematurity and permanent handicap in the newborn (Seoud et al., 1992; Yokoyama et al., 1995) . The perinatal mortality rate in IVF twin pregnancies (46.8 per 1000) is six times higher than that for singletons (Lieberman, 1998) and the risk of neurological problems, especially cerebral palsy (Stromberg et al., 2002) , substantially higher. Rearing of twins is also associated with practical difficulties for parents (Garel and Blondel, 1992; Doyle, 1996; Garel et al., 1997) , while health service costs associated with peri-natal care are formidable (Callahan et al., 1994; Goldfarb et al., 1996) .
The principal reason behind the large number of twin pregnancies in IVF is the policy of transferring multiple embryos within the uterus. In the USA, 62% of IVF cycles involved the transfer of three or more embryos (SART, 2002) while two embryos were replaced in 32% of cycles. While the most effective way to minimize multiple pregnancy is to limit the number of embryos transferred, such a policy has to be balanced against the risk of reducing overall pregnancy rates in IVF. Previously, a large observational study demonstrated that elective transfer of two embryos resulted in a significant reduction of triplet rates (Templeton and Morris, 1998) without compromising live birth rates. As a result, a two embryo transfer policy is now common in most European centres. However, even with two embryo transfer, the risk of twins remains high at 24% (Nyboe et al., 2005) , and a move to elective single embryo transfer has been proposed as the only means of limiting twins.
Initial uncertainty about single embryo transfer was based on data from observational studies suggesting relatively poor outcomes in cases where only one embryo was available for transfer. A study from Finland reported a 20.2% pregnancy rate where only one embryo was available versus 29.7% where one embryo was selected from an available pool of embryos. The cumulative pregnancy rate after frozen-thawed embryo transfers in the elective single embryo transfer group was 47.3% per oocyte retrieval. By comparison, the pregnancy rate for two embryo transfers was 29.4% per transfer and 23.9% of these were twin pregnancies (Vilska et al., 1999) .
Although more treatment cycles may be needed to achieve a similar live birth rate to two embryo transfers, the lower twin pregnancy rate of single embryo transfers may make this a safer and cost-effective option (Wolner-Hanssen and Rydhstroem, 1998) . The ultimate clinical decision to reduce the number of embryos for transfer will need to be based on the weight of the available evidence from randomized controlled trials.
Our aim was therefore to perform a systematic review of the literature to determine whether multiple pregnancy rates can be lowered by following a single embryo transfer policy without compromising clinical pregnancy rates.
Methods
We identified randomized controlled trials that compared elective two embryo transfer with elective single embryo transfer. Trials that evaluated the effectiveness of two embryo transfer versus fresh single embryo transfer followed by frozen-thawed single embryo transfer were also identified. We followed the search strategy developed for the Cochrane Menstrual Disorders and Subfertility Group (MDSG). Trials were identified from the group's specialized register of controlled trials (searched June 25, 2003) Randomized controlled trials were considered for inclusion in the review if they compared any of the following: elective two embryo transfer versus elective single embryo transfer, or the transfer of subsequent single frozen-thawed embryos. In cross-over trials, only data from the first phase (i.e. before cross-over) were used. Studies on embryo transfer at the blastocyst stage were excluded from the review.
The participants comprised subfertile women who underwent embryo transfer following IVF and/or ICSI treatment with their own gametes or as an oocyte/embryo donation recipient. Trials had to report live birth rate per woman/couple, cumulative live birth rate per woman/couple, pregnancy rate per woman/couple and multiple pregnancy rate per woman/couple as outcome measures.
Data extraction and assessment of trial quality were performed independently by two reviewers (Z.P. and S.B.). Additional information regarding trial methodology or original data was sought from the principal author of trials. Statistical analysis was performed in accordance with the guidelines developed by the MDSG. The outcomes were pooled statistically. Results for each trial were expressed as an odds ratio (OR) with 95% confidence intervals (CIs) and combined for meta-analysis with Rev Man software using the Peto-modified Mantel-Hanzel method.
Results
We identified four trials (Table I) where single embryo transfer was compared with double embryo transfer (Gerris et al., 1999; Martikainen et al., 2001; Lukassen et al., 2002; Thurin et al., 2004) . Outcomes included cumulative live birth rate, clinical pregnancy rate, live birth rate and multiple pregnancy rate. The sample was clinically heterogeneous but all the trials included subfertile women who underwent embryo transfer following IVF and/or ICSI with their own gametes or as an oocyte/embryo donation recipient. Women included were of good prognosis, i.e. younger women without a history of multiple failed IVF cycles, and with a number of embryos available for transfer. Only one trial reported live birth rates and cumulative live birth rates after a fresh elective single embryo transfer followed by single frozen and thawed embryo transfer (Thurin et al., 2004) . Table II shows the summary of results. In comparison with single embryo transfer, two embryo transfer in a fresh IVF/ICSI treatment cycle led to a significantly higher pregnancy rate (OR 2.16, 95% CI 1.65-2.82; P < 0.00001) and live birth rate per woman (OR 1.94, 95% CI 1.47-2.55, test for overall effect P < 0.00001) (Figure 1 ). The multiple pregnancy rate was significantly higher in women who had double embryo transfer (OR 23.55, 95% CI 8.00-69.29; P < 0.00001) (Figure 2) . The largest and most recent trial (Thurin et al., 2004 ) compared two policies: (i) the transfer of two fresh embryos; and (ii) the transfer of a single fresh embryo followed by a single frozen-thawed embryo. There were no significant differences in the cumulative live birth rates (OR 1.19, 95% CI 0.87-1.62, P = 0.3) (Figure 3 ) or clinical pregnancy rates (OR 1.21, 95% CI 0.89-1.64, P = 0.2) (Figure 3 ) between the two groups. Multiple pregnancy rates were significantly higher in women who had elective double embryo transfer (OR 62.83, 95% CI 8.52-463.57, P = 0.00005) (Figure 2 ).
Discussion
Elective single embryo transfer in a fresh IVF treatment cycle reduces multiple births but also lowers live birth and pregnancy rates in comparison with double embryo transfer. A single embryo transfer policy involving a fresh followed by a frozen embryo transfer reduces the risk of multiples while achieving a live birth rate comparable with that achieved by transferring two fresh embryos. We found no evidence of statistical heterogeneity among the trials included in this review, suggesting that variations among studies had little effect on overall conclusions.
All the trials included in this review (Gerris et al., 1999; Martikainen et al., 2001; Lukassen et al., 2002; Thurin et al., 2004) reported higher live birth rates per woman with double embryo transfer after fresh IVF treatment. This difference was not sustained in the largest trial on 660 women (Thurin et al., 2004) when the outcome of a fresh as well as the first frozen and thawed single embryo transfers was considered. Multiple pregnancy rates per woman/couple were significantly lower in women who underwent single embryo transfer in all four trials that were included in this comparison.
The results are based on relatively few trials (the total number of patients from four studies were 456 in the single embryo transfer group and 453 in the double embryo transfer group) and are dominated by a single trial (Thurin et al., 2004) . Even though there was no statistical heterogeneity among the trials, it is impossible to exclude an element of clinical heterogeneity. All the trials included 'good prognosis' women, i.e. younger women without a history of multiple failed IVF cycles and with a number of embryos available for transfer. The age criteria, however, were different for the included studies. Three trials (Gerris et al., 1999; Lukassen et al., 2002; Thurin et al., 2004) had an upper age limit of 34, 35 and 36 years, respectively. In a multicentre trial (Martikainen et al., 2001 ) that was included in this comparison, one centre did not take female age into account. The other centres in the trial included women younger than 36 years who were undergoing their first treatment cycle. In all four trials, only 'good quality' embryos were transferred. Three trials (Gerris et al., 1999; Martikainen et al., 2001; Thurin et al., 2004 ) defined a 'top quality embryo' in explicit terms but their criteria varied in each case. Embryo transfer was performed on day 3 in three trials (Gerris et al., 1999; Martikainen et al., 2001; Lukassen et al., 2002) . One trial included women who had embryo transfer on 2, 3 or 5 days (Thurin et al., 2004) . Ovarian stimulation protocols, oocyte retrieval and embryo transfer techniques, including embryo culture media and sperm preparations, were clearly described in three trials (Gerris et al., 1999; Martikainen et al., 2001; Thurin et al., 2004) , but not in the fourth (Lukassen et al., 2002) . Again there were variations in the techniques used. The methodological quality of the trials was variable. Two used computer-generated randomization (Martikainen et al., 2001; Thurin et al., 2004) . The others (Gerris et al., 1999; Lukassen et al., 2002) did not describe the method of randomization. Three studies randomized women just before embryo transfer (Gerris et al., 1999; Martikainen et al., 2001; Thurin et al., 2004) . One did not mention the timing of randomization (Lukassen et al., 2002) . Only one study explicitly described measures used for concealment of allocation (Gerris et al., 1999) . Three studies included explicit descriptions of methods of statistical analysis (Gerris et al., 1999; Martikainen et al., 2001; Thurin et al., 2004) . Intention to treat analysis was performed in a single trial (Thurin et al., 2004) which also was the only one to enforce double blinding. This trial included a power calculation and complete trial flow chart showing the number of withdrawals including cancellations, dropouts and women lost to follow-up (Thurin et al., 2004) .
Individually, none of the trials apart from the largest (Thurin et al., 2004) showed a statistically significant difference in pregnancy and live birth rates between elective single embryo transfer and elective double embryo transfer. Collectively, the combined OR based on 909 women favoured elective double embryo transfer in women undergoing a single fresh cycle of treatment with IVF. A potential advantage of elective single embryo transfer is that it offers an opportunity of freezing surplus embryos and utilizing these in successive treatments after thawing. Two of the trials presented data relating to outcome after transfer of single frozen and thawed embryos in a small group of women (Martikainen et al., 2001; Thurin et al., 2004) . In the first (Martikainen et al., 2001) , the outcome is similar in the elective single embryo transfer and elective double embryo transfer groups. However, the original randomization was not adhered to for frozen transfers (elective single embryo transfer and single frozen and thawed embryo transfer or subsequent single frozen and thawed embryo transfers), making these data impossible to interpret. The Scandinavian trial (Thurin et al., 2004) provides the most comprehensive data available so far. Even so, this trial does not allow for the possibility of frozen and thawed double embryo transfers or repeated (more than once) frozen and thawed single embryo transfers. Crucially, in the current IVF climate, it does not provide data on acceptability or costs. It will not come as a surprise to clinicians that a blanket policy of fresh elective single embryo transfer will minimize multiple pregnancy rates but also lower pregnancy rates per fresh IVF cycle. For such a policy to work, it needs to be selective in terms of identifying women at risk of twins (Vilska et al., 1999) . These women should ideally be younger than 35, in their first or second cycles of IVF, use fresh non-donor eggs or embryos and have a number of good quality embryos for future use. It is also important that success is defined in terms of cumulative live birth rates per oocyte retrieval and includes the outcomes of fresh as well as frozen embryo transfers (Templeton, 2000; Thurin et al., 2004) .
The feasibility and success of an elective single embryo transfer policy is limited by various national laws governing IVF treatment and funding issues. The new legislation in Sweden which enforces the routine use of single embryo transfer in eligible couples has led to a general implementation of single embryo transfer (ESHRE Campus Report, 2001 ). Elsewhere, if IVF is to be accessed in the private sector, patients might prefer multiple embryo transfer in order to maximize the chances of a live birth(s) at their first attempt. Single embryo transfer has worked well in European settings where IVF is subsidized. The existing system in other countries such as the USA and UK, whereby many couples pay for IVF, but not for neonatal care, is apt to discourage some couples from accepting elective single embryo transfer.
Currently, single embryo transfers are rare, accounting for only 6.2% of all fresh transfers in the USA (SART, 2002) and 12% of fresh transfers in Europe. Within Europe, there are enormous variations in practice, with rates varying from 30.5% in Finland to 7.3% in the UK (Nyboe et al., 2005) . This review demonstrates that it is possible for elective single embryo transfer to reduce risks in IVF without diminishing the chances of success, but debate continues about its feasibility in different clinical settings. Despite awareness of the risks of twins, consumers as well as service providers remain uncertain about adopting a single embryo transfer policy in routine clinical practice and continue to question its clinical and cost effectiveness. In order to answer these lingering doubts, there is a need for further large multi-centre randomized trials with a duration of follow-up incorporating fresh as well as frozen embryo replacements assessing not just clinical effectiveness, but also cost effectiveness and acceptability. 
